- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | AstraZeneca, Daiichi Sankyo's Enhertu Gets New US Approval for Two HER2-Positive Breast Cancer Indications | ||
| Mo | ProtaGene Teams With MilliporeSigma on End-to-End Testing | ||
| Mo | Triana Biomedicines Taps Dr. Mohan Bala as Chief Operating Officer | ||
| Mo | Piramal Pharma Solutions, Botanix Partner to Support Drug Substance Development | ||
| Mo | FDA Approves First Simponi Biosimilars in U.S. | ||
| Mo | Parabilis Medicines, Regeneron Partner to Advance Novel Antibody-Helicon Conjugates | ||
| 15.05. | Veracyte Gains Medicare Coverage for Muscle-Invasive Bladder Cancer Recurrence Monitoring Test | ||
| 15.05. | Valar Labs Gets FDA Breakthrough Device Nod for Vesta Bladder Cancer Risk Test | ||
| 15.05. | Telix to Explore PSMA-PET Imaging in Collaborations with EDAP and Profound | ||
| 14.05. | Terumo BCT, Steminent Join to Accelerate Late-Stage Clinical Manufacturing for Mesenchymal Stem Cell Therapies | ||
| 14.05. | Nuvation Bio Completes IBTROZI Manufacturing Tech Transfer to Thermo Fisher | ||
| 14.05. | Iterative Health Acquires Three Texas Cardiology Sites from NextStage Clinical Research | ||
| 14.05. | Degron Therapeutics Closes $40M Series A Extension Advancing Molecular Glue Degrader | ||
| 14.05. | OnCusp Therapeutics Taps Anthony Kim as Chief Financial Officer | ||
| 14.05. | Fosun Pharma, AriBio Sign Exclusive Global Option Agreement | ||
| 14.05. | IQVIA, Kexing Biopharm Expand Collaboration to Advance Biosimilar Development | ||
| 13.05. | Pfizer's Hympavzi Indication Expanded in EU for Treatment of Hemophilia A or B With Inhibitors | ||
| 13.05. | AstraZeneca to License Owkin AI Scientist for Development of Novel Biopharma Agents | ||
| 13.05. | Vetter Breaks Ground on New Site in Saarlouis | ||
| 13.05. | OrganaBio Acquires Excellos Operating Assets, Establishing Coast-to-Coast CDMO | ||
| 13.05. | Piramal Pharma Solutions Introduces Payload-Linker Development & Manufacturing Suite | ||
| 13.05. | Andelyn Biosciences Launches Lentiviral Vector Manufacturing Platform | ||
| 13.05. | Icon Expands Early Phase Capabilities | ||
| 13.05. | Infinimmune Appoints Srikanth Pendyala as Chief Medical Officer | ||
| 13.05. | Elpida Therapeutics, Catalent Partner for Late-Phase AAV Manufacturing |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.